aod9604 peptide weight loss evidence clinical trials AOD-9604 Research AOD9604 Peptide — 2mg, 5mg,

Reduces Fat Cell Size and Promotes Lipolysis Research indicates that NNMT inhibition leads to shrinkage of white adipose tissue and a shift toward fat oxidation , making the body more efficient at burning stored fat for energy

Researchers also examined metabolic and liver-related measurements

In obese mouse models: Animals treated with 5-Amino-1MQ lost significant fat mass compared to controls Effects were most pronounced in visceral adipose tissue the metabolically dangerous fat around organs No cardiovascular toxicity or significant off-target effects were observed at research doses Body weight decreased without appetite changes, suggesting the mechanism was purely metabolic Human data is limited this is still a research compound

There is no official female-only GHK-Cu dosage